Noom Med vs Sequence 2026: GLP-1 Weight Loss Programs Compared
An in-depth comparison of Noom Med and Sequence for GLP-1 weight loss. We examine pricing, coaching models, provider oversight, medication options, and clinical evidence side-by-side to help you decide, and show where a medication-focused provider like Trimi fits in.
Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. Our team updates competitor reviews when pricing, medication access, or program structures change so patients can compare options with current data.
Quick links: Semaglutide treatment, tirzepatide treatment, and cheapest GLP-1 injections guide.
More on GLP-1 Provider Comparisons
Noom vs Sequence for Weight Loss: What You Need to Know
If you are comparing noom vs sequence for GLP-1 weight loss, you are evaluating two of the most prominent coaching-plus-medication telehealth platforms in the market today. Noom Med pairs semaglutide prescriptions with the Noom app's behavioral psychology coaching. Sequence (now WW Med+ through WeightWatchers Clinic) pairs FDA-approved GLP-1 medications with WeightWatchers' program. Both position themselves as comprehensive weight management solutions rather than simple prescription platforms.
Noom Med vs Sequence, defined: Noom Med is the prescription arm of Noom, the popular calorie-tracking and behavioral change app, now expanded to include GLP-1 medications such as semaglutide and tirzepatide. Sequence was a telehealth weight loss company built around a provider-led care model; as of October 2026, joinsequence.com redirects to WeightWatchers, where the program is marketed as WW Med+ with medical services provided through WeightWatchers Clinic, which says it only prescribes FDA-approved medications. Both are legitimate telehealth providers with licensed medical teams, but they differ substantially in their approach: Noom Med leads with behavioral coaching, while WW Med+ (formerly Sequence) runs through WeightWatchers Clinic and bills GLP-1 medication separately from its membership.
The central question for most patients is whether either program's added services justify their cost. Clinical trial data consistently shows that GLP-1 medication is the primary driver of weight loss outcomes. The STEP 1 trial demonstrated 14.9% body weight loss with semaglutide at 68 weeks, with both the treatment and placebo groups receiving lifestyle counseling (Wilding et al., NEJM, 2021). The medication accounted for the clinical difference, not the counseling. Patients who want the medication without paying for app-based coaching may prefer a provider like Trimi, which offers compounded semaglutide at $99 per month and tirzepatide at $125 per month on its 12-month annual plan, with clinical oversight included; compounded medications are not FDA-approved.
Noom Med vs Sequence vs Trimi: Side-by-Side Comparison
| Feature | Noom Med | Sequence | Trimi |
|---|---|---|---|
| Semaglutide monthly cost | $149 to $209/mo | WW Med+ membership plus separately billed medication | $99/mo |
| Tirzepatide monthly cost | Limited availability | Membership plus separately billed Zepbound | $125/mo |
| Additional app/coaching fee | $32 to $70/mo possible | Part of the WW Med+ membership fee | None |
| Effective monthly total (sema) | $181 to $279/mo | WW Med+ membership plus separately billed medication | $99/mo |
| Care model | App-based CBT coaching | Medical services through WeightWatchers Clinic | Clinical guidance |
| Medication included in price | Yes (med subscription) | No (GLP-1 medication billed separately) | Yes |
| Flat dose-independent pricing | No | No | Yes |
| Provider visits included | Yes | Check WW Med+ plan details | Yes |
| Contract commitment | Varies by plan | 12-month or 6-month plan; auto-renews | $99/$125 annual plan is a 12-month commitment; month-to-month available at $175/$235 |
| Cancellation penalties | Possible | Plans auto-renew unless canceled; check your plan terms | Annual plan: 12-month commitment, backed by a 6-month money-back policy |
| 12-month total (semaglutide) | $2,172 to $3,348 | Membership plus medication; varies with insurance | $1,188 |
| Best for | Patients who value behavioral psychology coaching alongside medication | Patients who want an FDA-approved medication and may use commercial insurance | Patients wanting a flat published price for compounded GLP-1 care |
All pricing is approximate and based on publicly available information as of April 2026. Noom Med's effective monthly total includes the potential additional Noom app subscription fee. Verify current pricing directly with each provider before enrolling.
Pricing Breakdown: What You Actually Pay
Cost is the most significant differentiator when comparing Noom Med and Sequence. They are priced differently and for different reasons. Understanding the full cost picture requires looking beyond headline medication prices to capture app fees, dose escalation, and contract terms.
Noom Med Pricing
Noom Med charges $149 to $209 per month for its semaglutide medication subscription. This covers the prescription, clinical oversight, and medication delivery. However, Noom Med's behavioral coaching component often requires a separate Noom app subscription costing $32 to $70 per month depending on the plan and billing cycle. Some patients report bundled pricing that reduces the combined cost, but the total effective monthly expense for Noom Med with full coaching access typically ranges from $181 to $279 per month for semaglutide. Over twelve months, that totals $2,172 to $3,348 for medication and coaching combined. Noom Med's tirzepatide availability has been limited compared to other platforms. For a detailed look at potential side effects with this platform, see our guide on Noom Med side effects.
Sequence Pricing
As of October 2026, joinsequence.com redirects to WeightWatchers, where the program is marketed as WW Med+ with medical services provided through WeightWatchers Clinic. WeightWatchers lists WW Med+ at $25 for the first month with a 12-month or 6-month plan, then $74 per month on the 12-month plan or $84 per month on the 6-month plan, and says plans auto-renew at the same monthly rate unless canceled. WW Med+ does not include the cost of GLP-1 medications, which are billed separately; WeightWatchers says many medications are covered by insurance and that it also offers cash-pay options. For patients considering Sequence, our guide on Sequence weight loss side effects covers what to expect.
Trimi Pricing
Trimi charges $99 per month for semaglutide and $125 per month for tirzepatide. This price is flat and dose-independent, meaning you pay the same amount whether you are on a starting dose or a maintenance dose. There are no additional fees for app access, coaching, consultations, or shipping. The twelve-month total for semaglutide at Trimi is $1,188 with no risk of price escalation. Compared to Noom Med's midpoint cost of approximately $2,760, Trimi saves patients approximately $1,572 annually on semaglutide alone. For a broader comparison of affordable options, see our cheapest GLP-1 injections 2026 guide.
Annual Cost Perspective
GLP-1 therapy is typically sustained for at least 12 to 24 months for optimal results. A patient on Trimi at $99 per month spends $1,188 per year and $2,376 over two years.
Care Models Compared: Behavioral App vs WW Med+
Beyond the medication itself (WeightWatchers says WW Med+, formerly Sequence, only prescribes FDA-approved medications), the biggest difference between Noom Med and Sequence is the support model surrounding it. Noom Med leads with behavioral coaching through a technology-driven app. WW Med+ (formerly Sequence) runs through WeightWatchers' program, with medical services provided through WeightWatchers Clinic. These are fundamentally different philosophies, and understanding them is essential to choosing the right fit.
Noom Med: Behavioral Coaching
Rooted in cognitive behavioral therapy (CBT) principles
App-based daily lessons on food psychology and habit formation
Color-coded food classification system (green, yellow, red)
Daily calorie logging and meal tracking within the Noom app
Group coaching with other Noom users for peer accountability
Goal-setting and progress tracking tools integrated into the app
Focus on changing your psychological relationship with food
Sequence (WW Med+): Program Structure
Now marketed as WW Med+, with medical services provided through WeightWatchers Clinic
WeightWatchers says it only prescribes FDA-approved medications
12-month or 6-month plans that auto-renew unless canceled
GLP-1 medication billed separately from the membership
Insurance coordinators currently work only with commercial insurance plans; cash-pay options also offered
Noom Med is better suited for patients who want a structured behavioral program that addresses the psychological and habitual dimensions of eating alongside GLP-1 medication. The CBT-based framework is well-designed for patients who struggle with emotional eating, food noise, or difficulty translating nutrition knowledge into daily habits. The app creates a daily engagement loop that some patients find motivating and others find tedious after the first few weeks.
Sequence, now WW Med+ through WeightWatchers Clinic, may suit patients who want an FDA-approved medication and plan to use insurance: as of October 2026, WeightWatchers says many medications are covered by insurance and that its insurance coordinators currently work only with commercial insurance plans.
The premium services question
Noom Med charges a substantial premium for coaching, and WW Med+ (formerly Sequence) charges a membership fee on top of separately billed medication. The honest question is whether those services justify their added cost for you.
Clinical Evidence: What Actually Drives Weight Loss
Neither Noom Med nor Sequence has published peer-reviewed clinical trials demonstrating that their specific platform produces outcomes superior to GLP-1 medication with standard clinical oversight. The clinical evidence for GLP-1 weight loss comes from large-scale randomized controlled trials of the medications themselves, not from any individual telehealth platform's coaching methodology or provider oversight model.
Semaglutide: STEP 1 Trial Results
The landmark STEP 1 trial enrolled 1,961 adults and demonstrated that semaglutide 2.4 mg produced an average of 14.9% body weight loss over 68 weeks, compared to 2.4% with placebo. Critically, both groups received lifestyle counseling, meaning the medication, not the counseling, drove the 12.5 percentage point difference (Wilding et al., New England Journal of Medicine, 2021). This is the foundational evidence for semaglutide; the trial studied brand-name semaglutide, not compounded preparations, which are not FDA-approved.
Tirzepatide: SURMOUNT-1 Trial Results
The SURMOUNT-1 trial enrolled 2,539 adults and showed that tirzepatide produced 15% to 20.9% body weight loss over 72 weeks at various doses, compared to 3.1% with placebo. Both groups received lifestyle counseling. The dual GIP/GLP-1 mechanism of tirzepatide produced even greater weight loss than semaglutide alone (Jastreboff et al., New England Journal of Medicine, 2022). WW Med+ (formerly Sequence) offers brand-name Zepbound, and Trimi offers compounded tirzepatide, which is not FDA-approved. Noom Med's tirzepatide availability has been more limited.
Intensive Coaching vs Standard Counseling
A 2024 study by Wadden et al. in the New England Journal of Medicine compared semaglutide plus intensive behavioral therapy against semaglutide with standard counseling. Both groups lost significant weight, and the intensive therapy group did not demonstrate a clinically meaningful advantage over the standard counseling group. This directly challenges the value proposition of premium coaching programs, including those offered by Noom Med, and suggests that the incremental benefit of premium coaching beyond standard clinical guidance is minimal for most patients.
SELECT Cardiovascular Trial
The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events with semaglutide in patients with obesity and established cardiovascular disease (Lincoff et al., New England Journal of Medicine, 2023). This cardiovascular benefit is attributable to the medication itself, independent of any coaching methodology or provider oversight model, reinforcing that the pharmacological intervention is the primary therapeutic driver regardless of which platform prescribes it.
The clinical evidence is consistent: GLP-1 medications produce substantial, clinically meaningful weight loss. The medication drives the outcome. Behavioral coaching and premium provider oversight may provide supplementary value for certain patients, but they are not the primary mechanism of weight loss in GLP-1 treatment. This distinction matters because Noom Med charges a premium for coaching and WW Med+ (formerly Sequence) charges a membership fee on top of separately billed medication. Patients should decide whether those costs align with their individual needs and budget, knowing that the medication itself accounts for the vast majority of expected weight loss.
Who Should Choose Noom Med
Noom Med is the right fit if you specifically want Noom's behavioral psychology approach alongside your GLP-1 medication. Patients who have had success with the Noom app in the past and want to combine that methodology with prescription medication may find value in Noom Med's integrated experience. The CBT-based framework is well-designed for patients who struggle with emotional eating or food psychology and want structured daily guidance through an app they already know and trust.
Noom Med is not the right choice if cost is a significant factor. At $181 to $279 per month effective cost, Noom Med is expensive relative to medication-focused providers. The separate medication and app subscriptions can create billing complexity. Patients who are primarily interested in the medication and do not plan to engage deeply with daily app lessons may be paying a substantial premium for features they will not use. If you are currently on Noom Med and looking for alternatives, our guide to canceling Noom Med covers the transition process step by step.
Who Should Choose Sequence
Sequence, now WW Med+ through WeightWatchers Clinic, is the right fit if you want an FDA-approved brand-name medication and have commercial insurance: as of October 2026, WeightWatchers says many medications are covered by insurance, that its insurance coordinators currently work only with commercial insurance plans, and that it also offers cash-pay options, including self-pay Wegovy pill and Zepbound offers billed separately from the membership.
Sequence is not the right choice if you want a month-to-month plan: as of October 2026, WW Med+ uses 12-month or 6-month plans that auto-renew unless canceled, and GLP-1 medication is billed separately from the membership. If you are considering leaving Sequence, our guide to canceling Sequence walks through the process.
Who Should Choose Trimi
Trimi is the right fit if you want compounded GLP-1 treatment at a flat published price without paying for app-based coaching you may not fully use. Flat dose-independent pricing, no hidden fees, and responsive clinical support are the core of Trimi's model. The $99 and $125 rates are annual-plan prices carrying a 12-month commitment backed by a 6-month money-back policy; month-to-month is available at $175 and $235 and cancels at any time. Access to both semaglutide and tirzepatide at dose-independent pricing means your cost never increases as your treatment progresses through the titration schedule.
Trimi is not the right choice if you specifically want intensive app-based behavioral coaching (Noom Med) or an FDA-approved brand-name medication with WeightWatchers' program (WW Med+, formerly Sequence); Trimi's compounded medications are not FDA-approved. Trimi's model focuses on competent clinical medication management rather than comprehensive behavioral programming. The trade-off is clear: patients who choose Trimi forgo the supplementary platforms that Noom Med and Sequence provide. For patients who are self-motivated or prefer to manage their own nutrition and exercise alongside GLP-1 medication, this trade-off strongly favors Trimi.
The Bottom Line
Medication, not coaching, drove the trial results
In the STEP 1 and SURMOUNT-1 trials, brand-name semaglutide and tirzepatide produced 14.9% and 20.9% average weight loss. Those trials did not study compounded preparations, which are not FDA-approved. When you pay more at Noom Med, much of the premium goes to coaching; WW Med+ (formerly Sequence) says it only prescribes FDA-approved medications, which are billed separately from its membership.
Noom Med costs more than Trimi; Sequence's total depends on medication and insurance
For semaglutide over twelve months: Noom Med totals $2,172 to $3,348 and Trimi totals $1,188, a meaningful difference for a treatment that most patients sustain for at least 12 to 24 months. Sequence, now WW Med+ through WeightWatchers Clinic, bills GLP-1 medication separately from its membership, so its total depends on the medication prescribed and insurance coverage.
Start with the medication, add premium services if you need them
Rather than starting with an expensive coaching-plus-medication program and downgrading later, consider starting with a cost-effective medication provider like Trimi. If you find you need additional behavioral support after beginning treatment, standalone coaching apps are available independently, often at lower cost than the coaching premium charged by Noom Med.
Frequently Asked Questions
Is Noom Med the same as regular Noom?
No. Regular Noom is a behavioral weight loss app that uses cognitive behavioral therapy techniques without medication. Noom Med is a separate clinical program that pairs GLP-1 medications such as semaglutide with Noom's app-based coaching. Noom Med requires a medical evaluation and prescription. The Noom Med subscription covers medication and clinical oversight, but the Noom app subscription may be an additional $32 to $70 per month unless bundled into a combined plan.
Does Sequence prescribe tirzepatide?
Yes. Sequence is now WW Med+ through WeightWatchers Clinic, which says it only prescribes FDA-approved medications. As of October 2026, WeightWatchers lists self-pay Zepbound (tirzepatide) vials and KwikPens dispensed through LillyDirect pharmacy, billed separately from the WW Med+ membership.
Which is cheaper, Noom Med or Sequence?
It depends on the medication prescribed and your insurance coverage. Noom Med charges $149 to $209 per month for the medication subscription, with a possible additional Noom app fee of $32 to $70 per month. Sequence is now WW Med+ through WeightWatchers Clinic, which only prescribes FDA-approved medications and bills GLP-1 medication separately from its membership; WeightWatchers says many medications are covered by insurance. Noom Med is substantially more expensive than medication-focused providers like Trimi, which charges $99 per month for semaglutide with all clinical services included.
Do I need premium coaching to lose weight on GLP-1 medication?
Clinical evidence indicates that GLP-1 medication is the primary driver of weight loss. The STEP 1 trial demonstrated 14.9 percent body weight loss with semaglutide compared to 2.4 percent with placebo, and coaching was provided to both groups (Wilding et al., NEJM, 2021). A 2024 study by Wadden et al. found that intensive behavioral therapy alongside semaglutide did not produce a clinically meaningful advantage over standard counseling. Many patients achieve excellent results with medication and standard clinical oversight alone, without premium coaching or concierge provider programs.
Can I switch from Noom Med or Sequence to another provider?
Yes. Switching from Noom Med or Sequence to another GLP-1 provider is straightforward. Your new provider reviews your treatment history and decides whether to continue your GLP-1 therapy and at what dose; moving from a brand-name medication to a compounded preparation, which is not FDA-approved, is a clinical decision to make with that provider. The main consideration is timing the switch to avoid a gap in your medication supply. Review any contract terms or cancellation policies before switching. Detailed guides are available for canceling Noom Med and canceling Sequence.
Is Sequence (WW Med+) worth it compared to Noom Med?
Sequence is now WW Med+ through WeightWatchers Clinic. As of October 2026, WeightWatchers lists WW Med+ at $25 for the first month, then $74 per month on a 12-month plan or $84 per month on a 6-month plan, and GLP-1 medication is billed separately, so the total depends on the medication prescribed and your insurance coverage. Whether that is worth it compared with Noom Med depends on your clinical complexity and whether you want an FDA-approved brand-name medication. Individual results vary.
What happens if I stop paying for Noom Med coaching but want to keep my medication?
If you stop your Noom Med subscription, you lose access to both the platform services and your medication prescription. Noom Med bundles its value-added services with medication access, so you cannot keep one without the other. To continue GLP-1 treatment without coaching fees, you would need to transfer your care to a medication-focused provider like Trimi, which charges $99 per month for compounded semaglutide on the 12-month annual plan, with clinical oversight included. Compounded medications are not FDA-approved.
Sources & References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216.
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221-2232.
- Wadden TA, et al. Intensive behavioral therapy and semaglutide for obesity. N Engl J Med. 2024.
- Noom Health, Inc. Noom Med official program and pricing information. 2026.
- WeightWatchers. WW Med+ program and pricing information (joinsequence.com now redirects to WeightWatchers). Checked October 2026.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Individual results vary. Trimi is a competing provider; this comparison is presented fairly but readers should verify current pricing and program details directly with each provider. Pricing information reflects publicly available data as of April 2026 and is subject to change.